Company / Revenue
MANNKIND CORP Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$349.0M
FY2025
5-year range
$75.4M / $349.0M
FY2021-FY2025
Trend
+22.2%
vs FY2024
Sector context
#73 of 153
Health Care
What the data says
At $349M, MANNKIND CORP's revenue ranks #73 of 153 in the Health Care sector. Revenue has increased for 8 consecutive years, from $12M in FY2017 to $349M in FY2025.
Based on SEC 10-K filings.
$349M in FY2025 with a 5-year CAGR of +39.9%.
Improved from $199M to $349M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +51.8%
- 5-Year CAGR
- +39.9%
- 10-Year CAGR
- -
Sector benchmark
#73 of 153 in Health CareTop 48% of 153This company $349.0M Sector average $4.5B
▼
-92.3% below sector average
Key checks
Key Insights
- MANNKIND CORP's revenue has grown for 8 consecutive years.
- 5-year CAGR of +39.9%, indicating consistent growth.
- In FY2025, revenue increased 22.2% year-over-year.
- Ranks #73 out of 153 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.74 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $349.0M | +22.2% |
| FY2024 | $285.5M | +43.5% |
| FY2023 | $199.0M | +99.4% |
| FY2022 | $99.8M | +32.2% |
| FY2021 | $75.4M | +15.8% |
| FY2020 | $65.1M | +3.3% |
| FY2019 | $63.0M | +126.3% |
| FY2018 | $27.9M | +137.2% |
| FY2017 | $11.7M | -93.3% |
| FY2016 | $174.8M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026